# Pharmacokinetic Study of Single Doses of Clopidogrel, 75 mg and 300 mg, in Healthy Subjects

> **NCT01129063** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT01129063
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2010-08-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01129063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01129063, "Pharmacokinetic Study of Single Doses of Clopidogrel, 75 mg and 300 mg, in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01129063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*